When Dr. Jeremie LaRouche found himself staring down a 13,151-page medical record, he did what any self-respecting orthopaedic surgeon might do: he decided there had to be a better way.
That frustration became SiftMed, and on July 17, the St. John's-based startup announced it had closed a $5 million CAD seed round led by Staircase Ventures out of Toronto. The all-equity financing brings the company's total raise to just shy of $11 million—a war chest it plans to deploy in scaling an AI-powered platform that promises to do something decidedly unglamorous but potentially lucrative: help insurance carriers make sense of mountains of medical documentation.
The round, which closed in June, drew participation from The51, a new investor, alongside returning backers Pelorus VC, Sandpiper Ventures, and a clutch of founders from Verafin—the Newfoundland payments fraud detection company that Nasdaq acquired for $2.75 billion USD in 2020. That pedigree matters in a province not exactly known as a tech hub, though SiftMed seems intent on changing that calculus.
Doubling Down on Duplicates and Timelines
What SiftMed actually does is less exciting to describe than the problem it solves. The platform ingests unstructured medical records—the kind that arrive as faxed PDFs, scanned doctor's notes, and billing statements in no particular order—and turns them into something an insurance adjuster or legal team can actually work with. It removes duplicates, builds chronological timelines, extracts key details, and surfaces insights through what the company calls "source-linked outputs." Think of it as Marie Kondo for medical paperwork, except the stakes involve claim payouts rather than sock drawers.
There's also an AI assistant named Sifty, because apparently every enterprise software company in 2026 needs a chatbot with a name. To its credit, Sifty answers claims questions and cites its sources—crucial in an industry where getting the details wrong can mean litigation or regulatory trouble.
SiftMed claims on its website that it can cut medical record review time by 50 to 70 percent, with most processing wrapped up in under 30 minutes. The company itself reports accuracy rates north of 95 percent in identifying content, dates, and duplicates, and maintains SOC 2 Type II certification with HIPAA and PIPEDA compliance—table stakes for anyone handling sensitive health data in North America.
The roughly 30-person team serves property and casualty carriers dealing with auto bodily injury, workers' compensation, long-term disability, and general liability claims. Portage Mutual, a Canadian insurer, appears in a testimonial on the company's site, though SiftMed hasn't publicly disclosed a full client roster. (In enterprise software, NDAs often keep customer names under wraps longer than the CIA protects intelligence sources.)
The Valuation Question and the Numbers Behind It
BetaKit reported that the round priced at a significantly higher valuation than SiftMed's previous raises—a $2.728 million CAD seed in February 2023 and what was described as a $2.7 million CAD round in 2025—though specific valuation numbers were not disclosed. Staircase Ventures, in announcing the deal, noted that SiftMed is "more than doubling its revenue every six months," a growth clip that tends to get investors' attention even in cautious funding environments.
The company is chasing what Staircase pegs as a $26 billion medical claims review market. Whether that figure captures the full addressable opportunity or just the slice SiftMed can realistically compete for is the sort of detail that often gets smoothed over in funding announcements. Either way, it's a big enough sandbox that multiple players are now digging in.
An April interview with Entrevestor painted a picture of hockey-stick growth: 10× revenue expansion in 2025, with targets set for 4× ARR growth in 2026. Earlier in 2025, the company said it had signed its first enterprise insurance client in the first quarter, with average deal sizes growing fivefold since. SiftMed told BetaKit it expects to pursue a larger Series A within 12 to 18 months—venture-speak for "we're growing fast enough to need more capital soon, and we want you to know we're thinking about it."
What the Money Gets Spent On
According to a company blog post, the fresh capital will go toward deepening auditability and reporting features—critical capabilities for carriers that need to justify decisions to regulators or in court. SiftMed is also hiring across product, engineering, and marketing, the trifecta of functions that typically expand when a startup shifts from proving its concept to scaling it.
Co-founded by CEO Holly Hill and LaRouche, SiftMed emerged from that 13,000-plus-page medical record ordeal—a scenario that's evidently less rare than one might hope. Insurance adjusters and independent medical evaluators routinely wade through claims files that sprawl across thousands of pages, a process that's time-consuming, error-prone, and, let's be honest, mind-numbing.
A Crowded Field, With Room to Run
SiftMed isn't the only company chasing this problem. Fellow Canadian startup Wisedocs closed a $12.7 million CAD Series A in January 2024 and operates in a similar lane. Then there's DigitalOwl, a U.S./Israeli venture, and legaltech platforms like Filevine and Supio that have added medical review capabilities to broader case management suites. The competitive landscape is filling up, which can mean either validation of the market or a signal that differentiation will get harder as the space matures.
For now, SiftMed's bet is that carriers and their partners want purpose-built tools rather than general-purpose document processors. Whether that thesis holds—and whether the company can sustain its growth trajectory long enough to reach that Series A—will likely depend on how quickly it can sign up larger enterprise customers and prove out ROI at scale.
One thing seems clear: if you're an insurance adjuster still manually sorting through faxed medical records in 2026, someone in St. John's would very much like to have a word with you.
